Rigel Pharmaceuticals, Inc.

RIGL · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$56,746$32,786$24,459$18,890
Short-Term Investments$20,575$24,147$33,747$106,077
Receivables$41,615$30,550$40,320$15,472
Inventory$6,002$5,522$9,118$6,616
Other Curr. Assets$10,165$6,261$8,259$7,412
Total Curr. Assets$135,103$99,266$115,903$154,467
Property Plant & Equip (Net)$338$1,026$2,787$11,887
Goodwill$0$0$0$0
Intangibles$27,100$13,878$14,949$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,435$3,055$640$974
Total NC Assets$28,873$17,959$18,376$12,861
Other Assets$0$0$0$0
Total Assets$163,976$117,225$134,279$167,328
Liabilities
Payables$3,339$7,142$22,508$3,795
Short-Term Debt$7,557$7,921$1,133$9,892
Tax Payable$0$0$0$0
Deferred Revenue$27,795$17,039$13,514$10,511
Other Curr. Liab.$24,608$21,165$28,056$39,356
Total Curr. Liab.$63,299$53,267$65,211$63,554
LT Debt$52,408$52,658$40,420$20,673
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$44,981$39,944$42,264$52,727
Total NC Liab.$97,389$92,602$82,684$73,400
Other Liabilities$0$0$0$0
Cap. Leases$285$977$2,105$10,651
Total Liabilities$160,688$145,869$147,895$136,954
Equity
Pref Stock$0$0$0$0
Common Stock$18$17$174$172
Retained Earnings-$1,390,065-$1,407,550-$1,382,459-$1,323,886
AOCI$10$8-$153-$102
Other Equity$1,393,325$1,378,881$1,368,822$1,354,190
Total Equity$3,288-$28,644-$13,616$30,374
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$163,976$117,225$134,279$167,328
Net Debt$3,219$27,793$17,094$11,675